Double-carbapenem regimen, alone or in combination with colistin, in the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp)

J Infect. 2017 Jan;74(1):103-106. doi: 10.1016/j.jinf.2016.10.002. Epub 2016 Oct 25.

Authors

Affiliations

¹ Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Italy. Electronic address: alessandra.oliva@uniroma1.it.
² Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Italy.
³ Mediterranean Neurological Institute "Neuromed", Pozzilli, Italy.

PMID: 27793662
DOI: 10.1016/j.jinf.2016.10.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Bacterial Agents
Carbapenems
Colistin*
Humans
Klebsiella Infections
Klebsiella pneumoniae*
beta-Lactamases

Substances

Anti-Bacterial Agents
Carbapenems
beta-Lactamases
Colistin